BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32302553)

  • 1. Novel Drug Candidates Improve Ganglioside Accumulation and Neural Dysfunction in GM1 Gangliosidosis Models with Autophagy Activation.
    Kajihara R; Numakawa T; Odaka H; Yaginuma Y; Fusaki N; Okumiya T; Furuya H; Inui S; Era T
    Stem Cell Reports; 2020 May; 14(5):909-923. PubMed ID: 32302553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GM1-ganglioside-mediated activation of the unfolded protein response causes neuronal death in a neurodegenerative gangliosidosis.
    Tessitore A; del P Martin M; Sano R; Ma Y; Mann L; Ingrassia A; Laywell ED; Steindler DA; Hendershot LM; d'Azzo A
    Mol Cell; 2004 Sep; 15(5):753-66. PubMed ID: 15350219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel human model of the neurodegenerative disease GM1 gangliosidosis using induced pluripotent stem cells demonstrates inflammasome activation.
    Son MY; Kwak JE; Seol B; Lee DY; Jeon H; Cho YS
    J Pathol; 2015 Sep; 237(1):98-110. PubMed ID: 25925601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A GM1 gangliosidosis mutant mouse model exhibits activated microglia and disturbed autophagy.
    Liu S; Feng Y; Huang Y; Jiang X; Tang C; Tang F; Zeng C; Liu L
    Exp Biol Med (Maywood); 2021 Jun; 246(11):1330-1341. PubMed ID: 33583210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-diagnosing and managing patients with GM1 gangliosidosis and related disorders by the evaluation of GM1 ganglioside content.
    Tonin R; Caciotti A; Procopio E; Fischetto R; Deodato F; Mancardi MM; Di Rocco M; Ardissone A; Salviati A; Marangi A; Strisciuglio P; Mangone G; Casini A; Ricci S; Fiumara A; Parini R; Pavone FS; Guerrini R; Calamai M; Morrone A
    Sci Rep; 2019 Nov; 9(1):17684. PubMed ID: 31776384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generalized CNS disease and massive GM1-ganglioside accumulation in mice defective in lysosomal acid beta-galactosidase.
    Hahn CN; del Pilar Martin M; Schröder M; Vanier MT; Hara Y; Suzuki K; Suzuki K; d'Azzo A
    Hum Mol Genet; 1997 Feb; 6(2):205-11. PubMed ID: 9063740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sialidase NEU3 action on GM1 ganglioside is neuroprotective in GM1 gangliosidosis.
    Allende ML; Lee YT; Byrnes C; Li C; Tuymetova G; Bakir JY; Nicoli ER; James VK; Brodbelt JS; Tifft CJ; Proia RL
    J Lipid Res; 2023 Dec; 64(12):100463. PubMed ID: 37871851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-galactosidase-deficient mouse as an animal model for GM1-gangliosidosis.
    Matsuda J; Suzuki O; Oshima A; Ogura A; Noguchi Y; Yamamoto Y; Asano T; Takimoto K; Sukegawa K; Suzuki Y; Naiki M
    Glycoconj J; 1997 Sep; 14(6):729-36. PubMed ID: 9337086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered GM1 catabolism affects NMDAR-mediated Ca
    Weesner JA; Annunziata I; van de Vlekkert D; Robinson CG; Campos Y; Mishra A; Fremuth LE; Gomero E; Hu H; d'Azzo A
    Cell Rep; 2024 May; 43(5):114117. PubMed ID: 38630590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake and metabolism of radiolabelled GM1-ganglioside in skin fibroblasts from controls and patients with GM1-gangliosidosis.
    Midorikawa M; Inui K; Okada S; Yabuuchi H; Ogura K; Handa S
    J Inherit Metab Dis; 1991; 14(5):721-9. PubMed ID: 1779618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracerebroventricular enzyme replacement therapy with β-galactosidase reverses brain pathologies due to GM1 gangliosidosis in mice.
    Chen JC; Luu AR; Wise N; Angelis R; Agrawal V; Mangini L; Vincelette J; Handyside B; Sterling H; Lo MJ; Wong H; Galicia N; Pacheco G; Van Vleet J; Giaramita A; Fong S; Roy SM; Hague C; Lawrence R; Bullens S; Christianson TM; d'Azzo A; Crawford BE; Bunting S; LeBowitz JH; Yogalingam G
    J Biol Chem; 2020 Sep; 295(39):13532-13555. PubMed ID: 31481471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cyclodextrins on GM1-gangliosides in fibroblasts from GM1-gangliosidosis patients.
    Maeda Y; Motoyama K; Higashi T; Horikoshi Y; Takeo T; Nakagata N; Kurauchi Y; Katsuki H; Ishitsuka Y; Kondo Y; Irie T; Furuya H; Era T; Arima H
    J Pharm Pharmacol; 2015 Aug; 67(8):1133-42. PubMed ID: 25851126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid biomarkers showing neurodegeneration in dogs with GM1 gangliosidosis: possible use for assessment of a therapeutic regimen.
    Satoh H; Yamato O; Asano T; Yonemura M; Yamauchi T; Hasegawa D; Orima H; Arai T; Yamasaki M; Maede Y
    Brain Res; 2007 Feb; 1133(1):200-8. PubMed ID: 17196562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-butyldeoxygalactonojirimycin reduces neonatal brain ganglioside content in a mouse model of GM1 gangliosidosis.
    Kasperzyk JL; El-Abbadi MM; Hauser EC; D'Azzo A; Platt FM; Seyfried TN
    J Neurochem; 2004 May; 89(3):645-53. PubMed ID: 15086521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced autophagy and mitochondrial aberrations in murine G(M1)-gangliosidosis.
    Takamura A; Higaki K; Kajimaki K; Otsuka S; Ninomiya H; Matsuda J; Ohno K; Suzuki Y; Nanba E
    Biochem Biophys Res Commun; 2008 Mar; 367(3):616-22. PubMed ID: 18190792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous delivery of adeno-associated viral gene therapy in feline GM1 gangliosidosis.
    Gross AL; Gray-Edwards HL; Bebout CN; Ta NL; Nielsen K; Brunson BL; Lopez Mercado KR; Osterhoudt DE; Batista AR; Maitland S; Seyfried TN; Sena-Esteves M; Martin DR
    Brain; 2022 Apr; 145(2):655-669. PubMed ID: 34410345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G(M1)-ganglioside degradation and biosynthesis in human and murine G(M1)-gangliosidosis.
    Sano R; Trindade VM; Tessitore A; d'Azzo A; Vieira MB; Giugliani R; Coelho JC
    Clin Chim Acta; 2005 Apr; 354(1-2):131-9. PubMed ID: 15748609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GM1-gangliosidosis in a cross-bred dog confirmed by detection of GM1-ganglioside using electrospray ionisation-tandem mass spectrometry.
    Whitfield P; Johnson AW; Dunn KA; Delauche AJ; Winchester BG; Franklin RJ
    Acta Neuropathol; 2000 Oct; 100(4):409-14. PubMed ID: 10985700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical Enzyme Replacement Therapy with a Recombinant β-Galactosidase-Lectin Fusion for CNS Delivery and Treatment of GM1-Gangliosidosis.
    Weesner JA; Annunziata I; Yang T; Acosta W; Gomero E; Hu H; van de Vlekkert D; Ayala J; Qiu X; Fremuth LE; Radin DN; Cramer CL; d'Azzo A
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Filipin recognizes both GM1 and cholesterol in GM1 gangliosidosis mouse brain.
    Arthur JR; Heinecke KA; Seyfried TN
    J Lipid Res; 2011 Jul; 52(7):1345-51. PubMed ID: 21508255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.